[Remote] Director, Hub Operations at Dyno Therapeutics

Remote

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Bachelor’s degree
10+ years in healthcare, biotech, or pharmaceutical industry
4+ years in Hub Services, Patient Support Programs, Reimbursement, Access, Marketing, or Sales
Proven experience in new product launches and rare disease markets
Deep understanding of access and patient cost dynamics (Medicare Part B, Medicaid, commercial insurance)
Ability to work independently and collaborate cross-functionally
Strong planning, organizational, and communication skills
Entrepreneurial mindset and passion for building, learning, and innovation
Highly organized, detail-oriented, and committed to delivering quality results
Skilled at translating complex concepts for diverse audiences
Demonstrated problem-solving, intellectual curiosity, and ability to lead fast-paced projects with urgency
Hands-on expertise and proven track record as a team player and collaborator
Upholds the highest standards of professionalism, ethics, and integrity

Responsibilities

Provide strategic framework and guidance in the development and deployment of the patient access and support Hub
Build and manage relationships with Hub partner
Manage day-to-day operations of Hub program
Monitor Key Performance Indicators (KPIs) and Service Level Agreements (SLAs)
Exhibit ownership and accountability for all projects and internal assignments
Identify potential enhancements to the patient services programs while maintaining compliance
Facilitate routine operational meetings to address potential barriers in access to therapy
Maintain open communication throughout the organization
Exercise sound judgment and oversight to ensure integrity and compliance with company policies
Monitor industry trends and incorporate into program design and execution
Partner with Marketing on development of patient support program materials
Facilitate business reviews with Hub partner
Attend/staff/participate in meetings and/or conferences as requested by management
Develop annual strategies and tactics plan in collaboration with leadership

Skills

Key technologies and capabilities for this role

Patient AccessHub OperationsProgram ManagementMarket AccessStakeholder ManagementStrategic Planning

Dyno Therapeutics

Develops AI-optimized gene therapy vectors

About Dyno Therapeutics

Dyno Therapeutics focuses on advancing gene therapy by utilizing Artificial Intelligence to create Adeno-associated virus (AAV) vectors. These vectors are essential tools for delivering genetic material into cells, which is crucial for effective gene therapy. The company's AI technology enables the design and optimization of these vectors, potentially enhancing the success of gene therapies. Dyno collaborates with major pharmaceutical and biotech companies, such as Astellas, Roche, Sarepta, and Novartis, to develop therapies for various diseases affecting the skeletal and cardiac muscles, central nervous system, liver, and eyes. Unlike many competitors, Dyno's unique approach leverages AI to improve the performance of AAV vectors, setting it apart in the biotech field. The company's goal is to improve gene therapy outcomes through its advanced vector technology, ultimately benefiting patients with serious health conditions.

Watertown, MassachusettsHeadquarters

2018Year Founded

$106MTotal Funding

SERIES_ACompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Risks

Gene therapy investment slowdown may impact Dyno's growth and innovation.

Manufacturing bottlenecks could hinder scaling of Dyno's operations.

Increased competition from companies like Form Bio challenges Dyno's market position.

Differentiation

Dyno uses AI to design optimized AAV vectors for gene therapy.

Their AI-driven CapsidMap platform enhances AAV vector development for muscle gene therapies.

Partnerships with major pharma companies like Astellas and Roche boost Dyno's market presence.

Upsides

AI-driven capsid design improves delivery efficiency and reduces manufacturing costs.

Collaboration with NVIDIA enhances biological sequence design for gene therapies.

Generative AI increases efficiency of eye and brain-targeted capsid delivery significantly.

Land your dream remote job 3x faster with AI

Try Jobo Free